Ming H. Hong

300 Guangzhou Road
Nanjing, 210029, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 80 publications

Clinical characteristics and prognostic analysis of acute erythroid leukemia

Clinical characteristics and prognostic analysis of acute erythroid leukemia

Journal: Zhonghua nei ke za zhi

Published: May 08, 2026

Long-Term Results of Busulfan Plus High-Dose Idarubicin as a Conditioning Regimen to Autologous Stem Cell Transplantation Following Cytarabine Consolidation in Young Patients with Favorable or Intermediate-Risk Acute Myeloid Leukemia.

Long-Term Results of Busulfan Plus High-Dose Idarubicin as a Conditioning Regimen to Autologous Stem Cell Transplantation Following Cytarabine Consolidation in Young Patients with Favorable or Intermediate-Risk Acute Myeloid Leukemia.

Journal: Blood and lymphatic cancer : targets and therapy

Published: May 01, 2026

Renal Dysfunction in Patients with CML on Long-Term First-Line TKI Therapy: A Single-Center Analysis.

Renal Dysfunction in Patients with CML on Long-Term First-Line TKI Therapy: A Single-Center Analysis.

Journal: The oncologist

Published: April 01, 2026

Venetoclax Plus Blinatumoma as First Line Therapy for Newly Diagnosed Ph-Negative B-Cell Acute Lymphoblastic Leukemia.

Venetoclax Plus Blinatumoma as First Line Therapy for Newly Diagnosed Ph-Negative B-Cell Acute Lymphoblastic Leukemia.

Journal: Blood and lymphatic cancer : targets and therapy

Published: July 29, 2025

Venetoclax with azacitidine and dexamethasone: Non-cytotoxic induction therapy for T-cell leukemia and mixed-phenotype leukemia.

Venetoclax with azacitidine and dexamethasone: Non-cytotoxic induction therapy for T-cell leukemia and mixed-phenotype leukemia.

Journal: Therapeutic advances in hematology

Published: June 27, 2025

Identifying an immunogenic cell death-related gene signature and HSPA6 infers adverse prognosis in acute myeloid leukemia.

Identifying an immunogenic cell death-related gene signature and HSPA6 infers adverse prognosis in acute myeloid leukemia.

Journal: Journal of Cancer

Published: April 14, 2025

Smurf2 enhances ubiquitin-mediated degradation of CASC3 and attenuates leukemia progression.

Smurf2 enhances ubiquitin-mediated degradation of CASC3 and attenuates leukemia progression.

Journal: iScience

Published: April 14, 2025

Efficacy and safety analysis of venetoclax in combination with multidrug chemotherapy in patients with newly diagnosed acute leukemia of ambiguous lineage

Efficacy and safety analysis of venetoclax in combination with multidrug chemotherapy in patients with newly diagnosed acute leukemia of ambiguous lineage

Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi

Published: March 26, 2025

Splicing factor 3b subunit 1 mutation patterns and prognostic implications in myelodysplastic syndromes, acute myeloid leukemia, and chronic lymphocytic leukemia: A retrospective study of 1691 cases.

Splicing factor 3b subunit 1 mutation patterns and prognostic implications in myelodysplastic syndromes, acute myeloid leukemia, and chronic lymphocytic leukemia: A retrospective study of 1691 cases.

Journal: Cancer

Published: March 04, 2025

Acute Myeloid Leukemia Patients with High-Risk Karyotypes Benefit from Decitabine in Combination with Modified CAG.

Acute Myeloid Leukemia Patients with High-Risk Karyotypes Benefit from Decitabine in Combination with Modified CAG.

Journal: Biochemical genetics

Published: February 26, 2025

Single-cell transcriptome analysis defines novel molecular subtypes and reveals therapeutic implications of T/myeloid mixed-phenotype acute leukemia.

Single-cell transcriptome analysis defines novel molecular subtypes and reveals therapeutic implications of T/myeloid mixed-phenotype acute leukemia.

Journal: Genome medicine

Published: January 13, 2025

Efficacy and safety of gilteritinib combined with chemotherapy in newly diagnosed FLT3-mutated acute myeloid leukemia

Efficacy and safety of gilteritinib combined with chemotherapy in newly diagnosed FLT3-mutated acute myeloid leukemia

Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi

Published: January 07, 2025

Showing 1-12 of 80

Last Updated: 09/26/2026